Should sympathomimetics be available over the counter?
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to I Harrison.
Explore the source record for details and available documents.
We have measured the radiosensitization produced in hypoxic V79 cells in vitro by SR 2508, Ro-03-8799, and oxygen at conventional doses (0-30 Gy) as well as at low doses (0-4 Gy). Two techniques have been used: (a) FACS (Fluorescence Activated Cell Sorter) plating followed by the conventional colony formation assay and (b) microscopic scoring of surviving and non-surviving cells using the DMIPS (Dynamic Microscope Image Processing Scanner) system. The results show that the enhancement ratios (ER) for both drugs and for oxygen are dose dependent, decreasing somewhat at doses less than 4 Gy. The low dose sensitization measured at S = 0.8 for SR 2508, Ro-03-8799 and O2 was found to be approximately 73%, 61% and 75% of the high dose sensitization for these three agents, respectively. These values are not significantly different. Both the alpha- and beta-components of cell kill appeared to be sensitized by all three agents. The enhancement ratios obtained by the two different techniques are in general agreement, though some qualitative differences have been observed.
A single injection of reserpine in an adult horse was believed to induce toxicosis for several days. Clinical signs included erratic, colic-like behavior followed by depression, bradycardia, miosis, ptosis, and paraphimosis. Diarrhea was not observed and may have been due to the effect of xylazine given with the reserpine. The horse was supported with IV fluids and intensive nursing care. Gradual improvement was noted 72 hours after the horse received the drug. Qualitative analysis via high-performance liquid chromatography was positive for reserpine. Methamphetamine is the recommended antidote but was not used in this case.
In vitro studies in this laboratory indicated that at low radiation doses (0-3 Gy), sensitization by misonidazole diminishes. We have suggested that this results from a failure of misonidazole to enhance effectively the single-hit or alpha component of cell inactivation. Our low dose assay uses a partially automated microscopic analysis procedure which scores both surviving and killed cells. If enough cells are scored, this assay provides much better accuracy at low doses than the conventional assay. Recently, we have applied our low dose assay to a study of sensitization by diamide. This was done, in part, as a test of our assay system, since many investigators have shown that diamide substantially reduces the shoulder of the hypoxic cell survival curve. At high doses (D = 6.5 to 10 Gy, S = 0.1 to 0.01) we obtained for 150 microM diamide an enhancement ratio (ER) of 2.6 for hypoxic cells and 1.1 for aerobic cells. At low doses, 0-2.5 Gy, diamide still sensitized hypoxic cells well; with 150 microM diamide, the ER at 1 Gy (S = 0.8) was 2.0, about equal to the oxygen enhancement ratio (OER) at this dose. The fact that diamide shows good sensitization at low doses with our assay adds to the credibility of the assay and reduces the likelihood that our observations with misonidazole are an artifact of our system.
Explore the source record for details and available documents.
A surgical technique of open drainage, using penrose drains and pressure bandages, was used for the treatment of hygromata in four horses. In 3 cases with hygroma of the carpus, one with a secondary infection, there was complete resolution of the condition whereas in the one case with hygroma of the elbow resolution was more protracted because of difficulties in bandaging. The cosmetic and functional results after operation were most satisfactory.
Relative dose ratios of the mineralocorticoid antagonists spironolactone (100 mg and 200 mg daily) and canrenoate-K (200 mg daily) at steady state were defined in six healthy subjects with fludrecortisone as the mineralocorticoid agonist. The urine log 10 Na/K responses during spironolactone treatments were consistent with the law of mass action. The potency of canrenoate-K was 0.68 (95% C.L. 0.53 to 0.89) that of spironolactone on a weight basis. Approximately 72% of the renal antimineralocorticoid activity of spironolactone could attributed to the metabolite canrenone. The results at steady state are contrasted with those of a previously study comparing single doses of spironolactone and canrenoate-K.
The pharmacological activity of single doses of the two aldosterone antagonists, potassium canrenoate and spironolactone, was examined in two studies in healthy volunteers. Both drugs were active in reversing urinary electrolyte changes induced by fludrocortisone in periods 2 to 16 hr after treatment. Potassium canrenoate was significantly less potent that spironolactone on a weight or molar basis, with best estimates of the relative potency potassium canrenoate: spironolactone of approximately 0.3:1. On a weight basis the two drugs yielded plasma levels of the metabolite canrenone which were approximately equivalent. The results indicate that canrenone is not the principal pharmacologically active metabolite of spironolactone. Our study suggests that a major part of the renal antimineralocorticoid activity of spironolactone may be attributable to minor sulfur-containing metabolites or their precursors having a high renal clearance that affords access to their site of activity via the renal tubular fluid.
A case of massive upper gastrointestinal bleeding secondary to an ulcer within a Zenker's diverticulum is presented. The possible causes of the bleeding have been discussed, but the topical effect of aspirin intake appears to be the cause of bleeding in this case.
The potency of single doses of a new aldosterone antagonist, prorenoate, in reversing the renal effects of the synthetic mineralocorticoid fludrocortisone was compared to that of spironolactone in a double-blind balanced crossover study in 12 healthy subjects. The potency of prorenoate potassium as related to elevation of the urinary log 10 10 Na/K ratio (2.69:1) and as related to potassium retention (3.75:1) was significantly higher than that of spironolactone. Prorenoate produced greater natriuresis (1.64:1) but the difference was not significant. There was evidence for a qualitative difference between spironolactone and prorenoate; the latter significantly more potent in retaining potassium than in increasing sodium excretion. The simple methodology described is based on standard bioassay principles, yielded a valid and sensitive comparison of the two drugs, and should prove useful in the evaluation of other aldosterone antagonists.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.